Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain

Biomaterials

Volumn 31, Issue 36, 2010, Pages 9586-9594

  Culpepper, Bonnie K ^a   Phipps, Matthew C ^b   Bonvallet, Paul P ^b   Bellis, Susan L ^a,b  

^a and Radiation Oncology   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bone repair; Collagen; Hydroxyapatite; Mesenchymal stem cell; Peptide

Indexed keywords

BINDING DOMAIN; BIOACTIVE FACTOR; BIOACTIVE PEPTIDES; BONE FORMATION; BONE REPAIR; COLLAGEN MIMETIC PEPTIDES; DELIVERY SYSTEMS; ELECTROSPUNS; IN-VITRO; IN-VIVO; MESENCHYMAL STEM CELL; NANO PARTICULATES; OSSEOINTEGRATION; OSTEOBLASTIC DIFFERENTIATION; OSTEOCONDUCTIVITY; OSTEOGENESIS; PEPTIDE COUPLING; POLYGLUTAMATE;

APATITE; BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMIMETICS; BONE; CELL CULTURE; COLLAGEN; DISKS (MACHINE COMPONENTS); DISKS (STRUCTURAL COMPONENTS); HYDROXYAPATITE; REPAIR; STEM CELLS;

PEPTIDES;

COLLAGEN; HYDROXYAPATITE; POLYGLUTAMIC ACID;

ARTICLE; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CELL ADHESION; CELL DIFFERENTIATION; COLLAGEN; DURAPATITE; HUMANS; IMMOBILIZED PROTEINS; IMPLANTS, EXPERIMENTAL; MESENCHYMAL STEM CELLS; OLIGOPEPTIDES; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOGENESIS; POLYGLUTAMIC ACID; PROTEIN STRUCTURE, TERTIARY; TISSUE SCAFFOLDS;

RATTUS;

EID: 78149414076     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.020     Document Type: Article

References (64)

1. Geesink R.G. Osteoconductive coatings for total joint arthroplasty. Clin Orthop Relat Res 2002, 395:53-65.
2. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 2002, 395:81-98.
3. Hutmacher D.W., Schantz J.T., Lam C.X., Tan K.C., Lim T.C. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007, 1:245-260.
4. Tampieri A., Celotti G., Landi E. From biomimetic apatites to biologically inspired composites. Anal Bioanal Chem 2005, 381:568-576.
5. LeBaron R.G., Athanasiou K.A. Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng 2000, 6:85-103.
6. Durrieu M.C., Pallu S., Guillemot F., Bareille R., Amedee J., Baquey C.H., et al. Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J Mater Sci Mater Med 2004, 15:779-786.
7. Yang X.B., Bhatnagar R.S., Li S., Oreffo R.O. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 2004, 10:1148-1159.
8. Matsuura T., Hosokawa R., Okamoto K., Kimoto T., Akagawa Y. Diverse mechanisms of osteoblast spreading on hydroxyapatite and titanium. Biomaterials 2000, 21:1121-1127.
9. Kilpadi K.L., Chang P.L., Bellis S.L. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001, 57:258-267.
10. Hennessy K.M., Clem W.C., Phipps M.C., Sawyer A.A., Shaikh F.M., Bellis S.L. The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials 2008, 29:3075-3083.
11. Hennessy K.M., Pollot B.E., Clem W.C., Phipps M.C., Sawyer A.A., Culpepper B.K., et al. The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials 2009, 30:1898-1909.
12. Bruder S.P., Jaiswal N., Ricalton N.S., Mosca J.D., Kraus K.H., Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998, 284:S247-S256.
13. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999, 181:67-73.
14. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
15. Murphy M.B., Hartgerink J.D., Goepferich A., Mikos A.G. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules 2007, 8:2237-2243.
16. Itoh D., Yoneda S., Kuroda S., Kondo H., Umezawa A., Ohya K., et al. Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res 2002, 62:292-298.
17. Fujisawa R., Mizuno M., Nodasaka Y., Kuboki Y. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol 1997, 16:21-28.
18. Gilbert M., Giachelli C.M., Stayton P.S. Biomimetic peptides that engage specific integrin-dependent signaling pathways and bind to calcium phosphate surfaces. J Biomed Mater Res A 2003, 67:69-77.
19. Gilbert M., Shaw W.J., Long J.R., Nelson K., Drobny G.P., Giachelli C.M., et al. Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J Biol Chem 2000, 275:16213-16218.
20. Lee J.S., Murphy W.L. Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater 2010, 6:21-28.
21. Sawyer A.A., Weeks D.M., Kelpke S.S., McCracken M.S., Bellis S.L. The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion. Biomaterials 2005, 26:7046-7056.
22. Sawyer A.A., Hennessy K.M., Bellis S.L. The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials 2007, 28:383-392.
23. Stayton P.S., Drobny G.P., Shaw W.J., Long J.R., Gilbert M. Molecular recognition at the protein-hydroxyapatite interface. Crit Rev Oral Biol Med 2003, 14:370-376.
24. Hoang Q.Q., Sicheri F., Howard A.J., Yang D.S. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003, 425:977-980.
25. Ganss B., Kim R.H., Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999, 10:79-98.
26. Barber T.A., Ho J.E., De Ranieri A., Virdi A.S., Sumner D.R., Healy K.E. Peri-implant bone formation and implant integration strength of peptide-modified p(AAM-co-EG/AAC) interpenetrating polymer network-coated titanium implants. J Biomed Mater Res A 2007, 80:306-320.
27. Ho J.E., Barber T.A., Virdi A.S., Sumner D.R., Healy K.E. The effect of enzymatically degradable IPN coatings on peri-implant bone formation and implant fixation. J Biomed Mater Res A 2007, 81:720-727.
28. Catledge S.A., Clem W.C., Shrikishen N., Chowdhury S., Stanishevsky A.V., Koopman M., et al. An electrospun triphasic nanofibrous scaffold for bone tissue engineering. Biomed Mater 2007, 2:142-150.
29. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997, 64:295-312.
30. Kilpadi K.L., Sawyer A.A., Prince C.W., Chang P.L., Bellis S.L. Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite. J Biomed Mater Res A 2004, 68:273-285.
31. Castel S., Pagan R., Mitjans F., Piulats J., Goodman S., Jonczyk A., et al. RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways. Lab Invest 2001, 81:1615-1626.
32. Memmo L.M., McKeown-Longo P. The alphavbeta5 integrin functions as an endocytic receptor for vitronectin. J Cell Sci 1998, 111(Pt 4):425-433.
33. Rammelt S., Neumann M., Hanisch U., Reinstorf A., Pompe W., Zwipp H., et al. Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J Biomed Mater Res A 2005, 73:284-294.
34. Rammelt S., Schulze E., Witt M., Petsch E., Biewener A., Pompe W., et al. Collagen type I increases bone remodelling around hydroxyapatite implants in the rat tibia. Cells Tissues Organs 2004, 178:146-157.
35. Leupold J.A., Barfield W.R., An Y.H., Hartsock L.A. A comparison of ProOsteon, DBX, and collagraft in a rabbit model. J Biomed Mater Res B Appl Biomater 2006, 79:292-297.
36. Anderson J.M., Kushwaha M., Tambralli A., Bellis S.L., Camata R.P., Jun H.W. Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. Biomacromolecules 2009, 10:2935-2944.
37. Ripamonti U., Crooks J., Khoali L., Roden L. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs. Biomaterials 2009, 30:1428-1439.
38. Gomar F., Orozco R., Villar J.L., Arrizabalaga F. P-15 small peptide bone graft substitute in the treatment of non-unions and delayed union. A pilot clinical trial. Int Orthop 2007, 31:93-99.
39. Valentin A.H., Weber J. Receptor technology-cell binding to P-15: a new method of regenerating bone quickly and safely-preliminary histomorphometrical and mechanical results in sinus floor augmentations. Keio J Med 2004, 53:166-171.
40. Knight C.G., Morton L.F., Onley D.J., Peachey A.R., Messent A.J., Smethurst P.A., et al. Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem 1998, 273:33287-33294.
41. Knight C.G., Morton L.F., Peachey A.R., Tuckwell D.S., Farndale R.W., Barnes M.J. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 2000, 275:35-40.
42. Reyes C.D., Petrie T.A., Burns K.L., Schwartz Z., Garcia A.J. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 2007, 28:3228-3235.
43. Reyes C.D., Garcia A.J. Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res A 2004, 69:591-600.
44. Emsley J., Knight C.G., Farndale R.W., Barnes M.J. Structure of the integrin alpha2beta1-binding collagen peptide. J Mol Biol 2004, 335:1019-1028.
45. Wojtowicz A.M., Shekaran A., Oest M.E., Dupont K.M., Templeman K.L., Hutmacher D.W., et al. Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials 2010, 31:2574-2582.
46. Mizuno M., Kuboki Y. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J Biochem 2001, 129:133-138.
47. Takeuchi Y., Suzawa M., Kikuchi T., Nishida E., Fujita T., Matsumoto T. Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 1997, 272:29309-29316.
48. Mizuno M., Fujisawa R., Kuboki Y. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2beta1 integrin interaction. J Cell Physiol 2000, 184:207-213.
49. Salasznyk R.M., Williams W.A., Boskey A., Batorsky A., Plopper G.E. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 2004, 2004:24-34.
50. Carvalho R.S., Kostenuik P.J., Salih E., Bumann A., Gerstenfeld L.C. Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expression. Matrix Biol 2003, 22:241-249.
51. Xiao G., Wang D., Benson M.D., Karsenty G., Franceschi R.T. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 1998, 273:32988-32994.
52. Staatz W.D., Fok K.F., Zutter M.M., Adams S.P., Rodriguez B.A., Santoro S.A. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem 1991, 266:7363-7367.
53. Buhusi M., Midkiff B.R., Gates A.M., Richter M., Schachner M., Maness P.F. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem 2003, 278:25024-25031.
54. Mineur P., Guignandon A., Lambert Ch A., Amblard M., Lapiere Ch M., Nusgens B.V. RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblasts. Biochim Biophys Acta 2005, 1746:28-37.
55. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
56. Nygren H., Broberg M. Specific activation of platelets by surface-adsorbed plasma proteins. J Biomater Sci Polym Ed 1998, 9:817-831.
57. Wilson C.J., Clegg R.E., Leavesley D.I., Pearcy M.J. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 2005, 11:1-18.
58. Weathersby P.K., Horbett T.A., Hoffman A.S. A new method for analysis of the adsorbed plasma protein layer on biomaterial surfaces. Trans Am Soc Artif Intern Organs 1976, 22:242-252.
59. Preissner K.T. Structure and biological role of vitronectin. Annu Rev Cell Biol 1991, 7:275-310.
60. Mosher D.F. Physiology of fibronectin. Annu Rev Med 1984, 35:561-575.
61. Ruoslahti E. The RGD story: a personal account. Matrix Biol 2003, 22:459-465.
62. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996, 12:697-715.
63. Jang J.H., Castano O., Kim H.W. Electrospun materials as potential platforms for bone tissue engineering. Adv Drug Deliv Rev 2009, 61:1065-1083.
64. Vagaska B., Bacakova L., Filova E., Balik K. Osteogenic cells on bio-inspired materials for bone tissue engineering. Physiol Res 2010, 59:309-322.